Novel oral drug therapy combination shows promise for advanced melanoma patients

A research team led by Sheri Holmen, Ph.D., investigator at Huntsman Cancer Institute and professor in the Department of Surgery at the University of Utah (the U), is testing a new combination drug therapy that could both treat and prevent melanoma metastasis, or spreading from its original site, to the brain.

Leave A Comment

Your email address will not be published. Required fields are marked *